NYSE: BIO-B

Bio-RAD Laboratories, Inc. (BIO-B)

Bio-RAD Laboratories, Inc. is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE under the ticker BIO-B. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
BIO-B
Exchange
NYSE
SEC CIK
12208
Official filings
SEC EDGAR

Research BIO-B

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Bio-RAD Laboratories, Inc.'s stock ticker?

Bio-RAD Laboratories, Inc. trades under the ticker symbol BIO-B on NYSE. Its SEC Central Index Key (CIK) is 12208.

Where can I read Bio-RAD Laboratories, Inc.'s SEC filings?

The BIO-B SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Bio-RAD Laboratories, Inc. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze BIO-B's financial statements?

The BIO-B Financials page shows Bio-RAD Laboratories, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does BIO-B compare with its peers and the market?

The BIO-B Peer Comparison page lines Bio-RAD Laboratories, Inc. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.